Literature DB >> 22576147

Seeking new approaches: milrinone in the treatment of cerebral vasospasm.

Antoine Baumann, Anne-Laure Derelle, Paul-Michel Mertes, Gérard Audibert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22576147     DOI： 10.1007/s12028-012-9718-9

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  28 in total

1.  Ampulla (takotsubo) cardiomyopathy associated with subarachnoid hemorrhage worsening in the late phase of vasospasm--case report.

Authors:  Yasuki Ono; Tsuyoshi Kawamura; Jun Ito; Shigeaki Kanayama; Takeshi Miura; Fumitaka Kikuchi
Journal:  Neurol Med Chir (Tokyo)       Date:  2004-02       Impact factor: 1.742

2.  Frequency spectrum analysis of finger photoplethysmographic waveform variability during haemodialysis.

Authors:  Faizan Javed; Paul M Middleton; Philip Malouf; Gregory S H Chan; Andrey V Savkin; Nigel H Lovell; Elizabeth Steel; James Mackie
Journal:  Physiol Meas       Date:  2010-07-28       Impact factor: 2.833

3.  Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage.

Authors:  Jai Jai Shiva Shankar; Marlise P dos Santos; Leonardo Deus-Silva; Cheemun Lum
Journal:  Neuroradiology       Date:  2010-06-05       Impact factor: 2.804

4.  Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.

Authors:  Kazuya Nakamura; Fumitaka Ikomi; Toshio Ohhashi
Journal:  J Vasc Res       Date:  2005-11-11       Impact factor: 1.934

5.  Hyperdynamic therapy for cerebral vasospasm.

Authors:  H Hadeishi; M Mizuno; A Suzuki; N Yasui
Journal:  Neurol Med Chir (Tokyo)       Date:  1990-05       Impact factor: 1.742

Review 6.  Novel treatments for vasospasm after subarachnoid hemorrhage.

Authors:  Carl Muroi; Martin Seule; Kenichi Mishima; Emanuela Keller
Journal:  Curr Opin Crit Care       Date:  2012-04       Impact factor: 3.687

7.  High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage.

Authors:  Neil Rosenberg; Marc A Lazzaro; Demetrius K Lopes; Shyam Prabhakaran
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

8.  Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage.

Authors:  Richard E Temes; Elena Tessitore; J Michael Schmidt; Andrew M Naidech; Andres Fernandez; Noeleen D Ostapkovich; Jennifer A Frontera; Katja E Wartenberg; Marco R Di Tullio; Neeraj Badjatia; E Sander Connolly; Stephan A Mayer; Augusto Parra
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

9.  Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation.

Authors:  Gérard Audibert; Gaëlle Steinmann; Nicole de Talancé; Marie-Hélène Laurens; Pierre Dao; Antoine Baumann; Dan Longrois; Paul-Michel Mertes
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

10.  Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen.

Authors:  Gabriel Zada; Sergei Terterov; Jonathan Russin; Leonardo Clavijo; Steven Giannotta
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210
View more
  2 in total

1.  Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review.

Authors:  Alex Goes Santos-Teles; Clara Ramalho; João Gabriel Rosa Ramos; Rogério da Hora Passos; André Gobatto; Suzete Farias; Paulo Benígno Pena Batista; Juliana Ribeiro Caldas
Journal:  Rev Bras Ter Intensiva       Date:  2020 Oct-Dec

2.  Improvement in Sonographic Vasospasm Following Intravenous Milrinone in a Subarachnoid Hemorrhage Patient with Normal Cardiac Function.

Authors:  Nakul Katyal; Pravin George; Premkumar Nattanamai; Larry N Raber; Jonathan M Beary; Christopher R Newey
Journal:  Cureus       Date:  2018-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.